Related Experiment Video
Updated: Feb 9, 2026
![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=50)
An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
Published on: May 24, 2024
Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice
1aCenter for Global Health, Massachusetts General Hospital bDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Adherence to oral pre-exposure prophylaxis (PrEP) is generally high in real-world settings, offering reliable HIV prevention. Future efforts should focus on context-specific adherence goals aligned with individual HIV risk and prevention choices.
Area of Science:
- Public Health
- Infectious Disease Prevention
- Pharmacology
Background:
- Oral pre-exposure prophylaxis (PrEP) is a key biomedical strategy for HIV prevention.
- Understanding and optimizing adherence to PrEP is crucial for its effectiveness in real-world settings.
- Adherence measurement and support strategies require ongoing evaluation and refinement.
Purpose of the Study:
- To review the current understanding of adherence to oral PrEP.
- To examine methods for measuring PrEP adherence.
- To discuss approaches for supporting PrEP adherence and defining adherence goals within HIV prevention.
Main Methods:
- Literature review of studies on PrEP adherence.
- Analysis of adherence rates in clinical trials, extensions, and demonstration projects.
- Exploration of adherence monitoring technologies and intervention strategies.
Main Results:
- PrEP adherence has been higher in recent trials and demonstration projects compared to initial clinical trials.
- Adherence monitoring has explored electronic pill containers, SMS reminders, and drug concentrations.
- Interventions include enhanced counseling, objective adherence feedback, and SMS support.
- The conceptualization of PrEP adherence is shifting from 100% to context-dependent goals based on HIV exposure risk.
Conclusions:
- PrEP adherence outside of clinical trials is generally sufficient for effective HIV prevention.
- Future efforts should prioritize measuring and supporting adherence based on individual HIV risk and dynamic prevention choices.
Related Concept Videos
Area of a Surface of Revolution
Volumes of Solids of Revolution
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Centroid for the Paraboloid of Revolution
The centroid for the paraboloid of revolution is the point where all the mass of the paraboloid is concentrated. This centroid is important for engineering applications, as it determines how forces are...

